Sinopharm Group financials at a glance

+ Portfolio

The revenue of Sinopharm Group is reported as 596.56957 billion Dollars in the fiscal year 2023. The earnings were 2.9 Dollars per share in 2023, which was 6.23 higher than 2022. And about 4.2245 billion Dollars are reported as free cash flow in the financials of Sinopharm Group 2023. Dividends of 0.86 Dollars per share were paid to shareholders of Sinopharm Group stock SEHK:1099 in fiscal 2023.

HK$596.57B

Revenue

HK$2.90

Earnings Per Share

8.13%

Gross Margin %

HK$6.70B

Free Cash Flow

Revenue

596,569.57

Earnings Per Share

2.90

Gross Margin %

8.13

Free Cash Flow

6,699.00

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
Rev.	Revenue	N/A	HK$596.57B	HK$552.15B	HK$521.05B	HK$456.41B	HK$425.27B	HK$344.53B	HK$277.72B	HK$258.39B	HK$227.07B	HK$200.13B	HK$166.87B	HK$135.79B	HK$102.22B	HK$69.23B	HK$47.05B
GM %	Gross Margin %	8.21%	8.13%	8.59%	8.45%	8.83%	8.83%	9.06%	8.45%	8.00%	8.19%	8.16%	8.02%	8.05%	8.17%	8.43%	8.37%
OM	Operating Margin	3.80%	3.74%	4.12%	4.03%	4.19%	4.27%	4.47%	4.26%	3.95%	4.03%	3.92%	3.64%	3.57%	3.56%	3.48%	3.59%
EPS	Earnings Per Share	HK$2.81	HK$2.90	HK$2.73	HK$2.49	HK$2.31	HK$2.10	HK$2.04	HK$1.91	HK$1.68	HK$1.36	HK$1.11	HK$0.89	HK$0.82	HK$0.66	HK$0.51	HK$0.47
Div.	Dividends	N/A	HK$0.86	HK$0.82	HK$0.75	HK$0.69	HK$0.60	HK$0.59	HK$0.57	HK$0.50	HK$0.41	HK$0.31	HK$0.26	HK$0.25	HK$0.16	HK$0.16	HK$0.01
PR %	Payout Ratio %	0	29.66%	30.04%	30.12%	29.87%	28.57%	28.92%	29.84%	29.76%	30.15%	27.93%	29.21%	30.49%	24.24%	31.37%	2.13%
Sha.	Shares	N/AM	3,120.66M	3,120.66M	3,120.66M	3,120.66M	2,969.65M	2,967.63M	3,170.1M	2,767.1M	2,767.1M	2,767.1M	2,568.29M	2,402.63M	2,402.63M	2,264.57M	2,264.57M
OCF	Operating Cash Flow	N/A	HK$6.18B	HK$20.96B	HK$9.31B	HK$11.15B	HK$18.78B	HK$3.65B	HK$1.67B	HK$9.26B	HK$13.56B	HK$5.56B	HK$4.94B	HK$4.02B	HK$1.02B	HK$1.20B	HK$1.01B
FCF	Free Cash Flow	N/A	HK$6.70B	HK$18.48B	HK$6.50B	HK$-4,574.09M	HK$13.91B	HK$-,212.13M	HK$-,896.14M	HK$7.79B	HK$11.43B	HK$2.66B	HK$874.92M	HK$1.46B	HK$-3,943.43M	HK$-1,498.00M	HK$477.05M
FCFS	Free Cash Flow Per Share	HK$3.38	HK$4.78	HK$5.98	HK$2.27	HK$2.92	HK$5.53	HK$0.13	HK$0.33	HK$2.87	HK$4.40	HK$1.42	HK$1.45	HK$1.04	HK$-0.05	HK$-0.12	HK$0.29

Sinopharm Group financials at a glance

Financials

Discover